269 related articles for article (PubMed ID: 25386936)
1. Neoadjuvant therapy for breast cancer.
Zardavas D; Piccart M
Annu Rev Med; 2015; 66():31-48. PubMed ID: 25386936
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant endocrine treatment in primary breast cancer - review of literature.
Mathew J; Asgeirsson KS; Jackson LR; Cheung KL; Robertson JF
Breast; 2009 Dec; 18(6):339-44. PubMed ID: 19836953
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant use of endocrine therapy in breast cancer.
Macaskill EJ; Dixon JM
Breast J; 2007; 13(3):243-50. PubMed ID: 17461898
[TBL] [Abstract][Full Text] [Related]
4. [Neoadjuvant antihormonal treatment of women with breast cancer].
Tuxen MK; Kamby C; Nielsen DL
Ugeskr Laeger; 2007 Sep; 169(37):3077-81. PubMed ID: 17877952
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant endocrine therapy for breast cancer: an overlooked option?
Wong ZW; Ellis MJ
Oncology (Williston Park); 2004 Apr; 18(4):411-20; discussion 421, 424, 429 passim. PubMed ID: 15134351
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based neoadjuvant endocrine therapy for breast cancer.
Dienstmann R; Bines J
Clin Breast Cancer; 2006 Oct; 7(4):315-20. PubMed ID: 17092398
[TBL] [Abstract][Full Text] [Related]
7. [Neoadjuvant systemic therapy in breast cancer].
Kahán Z; Nikolényi A; Uhercsák G; Thurzó L
Orv Hetil; 2009 Jan; 150(2):65-71. PubMed ID: 19103557
[TBL] [Abstract][Full Text] [Related]
8. Clinical and biomarker endpoint analysis in neoadjuvant endocrine therapy trials.
Tao Y; Klause A; Vickers A; Bae K; Ellis M
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):91-5. PubMed ID: 15994076
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant endocrine treatment in breast cancer: analysis of daily practice in large cancer center to facilitate decision making.
Debled M; Auxepaules G; de Lara CT; Garbay D; Brouste V; Bussières E; Mauriac L; MacGrogan G
Am J Surg; 2014 Nov; 208(5):756-763. PubMed ID: 24814311
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant endocrine therapy in breast cancer.
Abrial C; Mouret-Reynier MA; Curé H; Feillel V; Leheurteur M; Lemery S; Le Bouëdec G; Durando X; Dauplat J; Chollet P
Breast; 2006 Feb; 15(1):9-19. PubMed ID: 16230013
[TBL] [Abstract][Full Text] [Related]
11. Facilitating breast-conserving surgery and preventing recurrence: aromatase inhibitors in the neoadjuvant and adjuvant settings.
Mamounas EP
Ann Surg Oncol; 2008 Mar; 15(3):691-703. PubMed ID: 18196346
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer (non-metastatic).
Rodger A; Stebbing J; Thompson AM
Clin Evid; 2006 Jun; (15):2360-92. PubMed ID: 16973090
[No Abstract] [Full Text] [Related]
13. Surgical issues surrounding use of aromatase inhibitors.
Dixon JM; Renshaw L; Murray J; Macaskill EJ; Young O; Miller WR
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):97-103. PubMed ID: 16023854
[TBL] [Abstract][Full Text] [Related]
14. Safely promoting breast-conserving surgery and preventing early relapses with an aromatase inhibitor.
Markopoulos C
Surg Oncol; 2008 Aug; 17(2):113-28. PubMed ID: 18178077
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response.
Jones RL; Smith IE
Lancet Oncol; 2006 Oct; 7(10):869-74. PubMed ID: 17012049
[TBL] [Abstract][Full Text] [Related]
16. Drug development: neoadjuvant opportunities in breast cancer.
Rastogi P; Geyer CE; Mamounas EP; DeMichele A
Am Soc Clin Oncol Educ Book; 2013; ():73-9. PubMed ID: 23714461
[TBL] [Abstract][Full Text] [Related]
17. Endocrine therapy in breast cancer: the neoadjuvant, adjuvant, and metastatic approach.
Reinbolt RE; Mangini N; Hill JL; Levine LB; Dempsey JL; Singaravelu J; Koehler KA; Talley A; Lustberg MB
Semin Oncol Nurs; 2015 May; 31(2):146-55. PubMed ID: 25951743
[TBL] [Abstract][Full Text] [Related]
18. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
Gralow JR; Burstein HJ; Wood W; Hortobagyi GN; Gianni L; von Minckwitz G; Buzdar AU; Smith IE; Symmans WF; Singh B; Winer EP
J Clin Oncol; 2008 Feb; 26(5):814-9. PubMed ID: 18258991
[TBL] [Abstract][Full Text] [Related]
19. Role of endocrine therapy in the neoadjuvant surgical setting.
Dixon JM
Ann Surg Oncol; 2004 Jan; 11(1 Suppl):18S-23S. PubMed ID: 15015705
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.
Smith IE; Dowsett M; Ebbs SR; Dixon JM; Skene A; Blohmer JU; Ashley SE; Francis S; Boeddinghaus I; Walsh G;
J Clin Oncol; 2005 Aug; 23(22):5108-16. PubMed ID: 15998903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
